IBEX (NASDAQ:IBEX – Get Free Report) is expected to post its Q1 2027 results after the market closes on Thursday, November 5th. Analysts expect the company to announce earnings of $0.90 per share and revenue of $169.31 million for the quarter. Individuals may visit the company’s upcoming Q1 2027 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.
IBEX (NASDAQ:IBEX – Get Free Report) last posted its quarterly earnings results on Friday, September 11th. The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.84 by $0.01. The business had revenue of $164.27 million during the quarter, compared to analysts’ expectations of $160.02 million. IBEX had a net margin of 7.19% and a return on equity of 28.96%.
IBEX Stock Performance
IBEX opened at $44.72 on Tuesday. The company has a market cap of $596.74 million, a PE ratio of 14.29 and a beta of 0.69. IBEX has a 52-week low of $25.94 and a 52-week high of $48.17. The stock has a 50-day moving average of $42.33 and a 200-day moving average of $34.35.
Insiders Place Their Bets
In related news, CEO Robert Dechant sold 25,000 shares of the business’s stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $39.99, for a total value of $999,750.00. Following the sale, the chief executive officer owned 262,011 shares of the company’s stock, valued at $10,477,819.89. The trade was a 8.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Christina O’Connor sold 7,500 shares of the stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $40.30, for a total value of $302,250.00. Following the completion of the transaction, the insider owned 29,231 shares in the company, valued at approximately $1,178,009.30. The trade was a 20.42% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 97,465 shares of company stock worth $3,882,291. Company insiders own 3.40% of the company’s stock.
Wall Street Analysts Forecast Growth
IBEX has been the subject of several research reports. Weiss Ratings raised IBEX from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, October 12th. Robert W. Baird lifted their target price on shares of IBEX from $40.00 to $44.00 and gave the stock a “neutral” rating in a report on Monday, September 28th. Finally, Wall Street Zen downgraded IBEX from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 12th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $42.00.
Check Out Our Latest Report on IBEX
IBEX Company Profile
IBEX Limited (NASDAQ: IBEX) is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services.
The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.
Further Reading
- Five stocks we like better than IBEX
- SpaceX Sent Verizon and T-Mobile Stocks Tumbling—Did Wall Street Overreact?
- SpaceX Starlink’s Telecom Ground Game Takes Shape
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
Receive News & Ratings for IBEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBEX and related companies with MarketBeat.com's FREE daily email newsletter.
